VOYA Investment Management
TPST icon

VOYA Investment Management’s Tempest Therapeutics TPST Stock Holding History

VOYA Investment Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5
Closed -$29K – 2654
2017
Q1 		$29K Hold
5
– – ﹤0.01% 2497
2016
Q4 		$24K Hold
5
– – ﹤0.01% 2520
2016
Q3 		$111 Hold
5
– – ﹤0.01% 2454
2016
Q2 		$81K Buy
5
+1
+25% +$22.8K ﹤0.01% 2509
2016
Q1 		$109K Hold
4
– – ﹤0.01% 2381
2015
Q4 		$112K Hold
4
– – ﹤0.01% 2461
2015
Q3 		$98K Hold
4
– – ﹤0.01% 2493
2015
Q2 		$333K Buy
4
+2
+100% +$183K ﹤0.01% 2187
2015
Q1 		$249K Buy
+2
New +$266K ﹤0.01% 2346

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VOYA Investment Management's TPST Position: Q2 2017 in Review

VOYA Investment Management sold out of Tempest Therapeutics (TPST) in Q2 2017, closing a stake of 5 shares — an estimated $29K sold.

VOYA Investment Management first reported a position in TPST in Q1 2015 and held it in 9 quarters. The position peaked at $333K in Q2 2015. 54 funds tracked by Wall St. Rank hold TPST as of Q2 2017.

  • VOYA Investment Management reported no remaining Tempest Therapeutics position as of Q2 2017 after selling out during the quarter.
  • VOYA Investment Management sold 5 Tempest Therapeutics shares in Q2 2017, an estimated $29K.
  • VOYA Investment Management first reported a position in Tempest Therapeutics in Q1 2015 and held it in 9 quarters.
  • VOYA Investment Management's Tempest Therapeutics position peaked at $333K in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2017.

Based on VOYA Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.